REGN
Regeneron Pharmaceuticals, Inc.
Stock
$735.20+0.39 (+0.05%)Close Oct 2, 2026
- Free cash flow, 2025
- $4.1B
- YoY, 2025
- +11.3%
- 5-year CAGR
- +15.3%
- 10-year CAGR
- +20.1%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $4.1B | +11.3% |
| 2024 | $3.7B | −5.4% |
| 2023 | $3.9B | −12.4% |
| 2022 | $4.4B | −32.2% |
| 2021 | $6.5B | +225.9% |
| 2020 | $2.0B | +0.2% |
| 2019 | $2.0B | +10.4% |
| 2018 | $1.8B | +75.2% |
| 2017 | $1.0B | +6.2% |
| 2016 | $974M | +49.2% |
| 2015 | $653M | +55.7% |
| 2014 | $419M | −3.0% |
| 2013 | $432M | — |
| 2012 | −$124M | — |
| 2011 | −$199M | — |
| 2010 | −$467K | — |
| 2009 | −$167M | — |
| 2008 | −$124M | — |